Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,387,438
+$815,449 QoQ
Shares Held
5,463
+133.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2,678
of 4,676 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Storgate, LLC holds $10,625,067 across 7 Drug Manufacturers - General names. JNJ ranks #5 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,218 | $2,660,335 | |
| 2 | MRK |
Merck & Co., Inc.
|
20,013 | $2,571,670 | |
| 3 | PFE |
Pfizer Inc
|
71,316 | $1,717,289 | |
| 4 | SNY |
Sanofi
|
33,157 | $1,414,477 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
5,463 | $1,387,438 | |
| 6 | ABBV |
AbbVie Inc.
|
2,463 | $619,789 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,011 | $254,069 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,387,438 | 5,463 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $571,989 | 2,340 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $710,252 | 3,432 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||